Tango Therapeutics, Inc. (TNGX)
NASDAQ: TNGX · Real-Time Price · USD
12.61
-0.08 (-0.63%)
Feb 11, 2026, 4:00 PM EST - Market closed
Tango Therapeutics Employees
Tango Therapeutics had 155 employees as of December 31, 2024. The number of employees increased by 15 or 10.71% compared to the previous year.
Employees
155
Change (1Y)
15
Growth (1Y)
10.71%
Revenue / Employee
$429,039
Profits / Employee
-$648,484
Market Cap
1.70B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 155 | 15 | 10.71% |
| Dec 31, 2023 | 140 | 30 | 27.27% |
| Dec 31, 2022 | 110 | 19 | 20.88% |
| Sep 30, 2022 | 109 | 26 | 31.33% |
| Jun 30, 2022 | 103 | 17 | 19.77% |
| Mar 31, 2022 | 98 | 21 | 27.27% |
| Dec 31, 2021 | 91 | 14 | 18.18% |
| Sep 30, 2021 | 83 | 6 | 7.79% |
| Jun 30, 2021 | 86 | - | - |
| Mar 31, 2021 | 77 | - | - |
| Dec 31, 2020 | 77 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Immunocore Holdings | 493 |
| Vericel | 357 |
| Nurix Therapeutics | 317 |
| Zymeworks | 263 |
| Precigen | 143 |
| Innoviva | 127 |
| Definium Therapeutics | 74 |
| Enliven Therapeutics | 65 |
TNGX News
- 4 weeks ago - Tango Therapeutics, Inc. (TNGX) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 4 weeks ago - Tango Therapeutics Announces CEO Transition: Barbara Weber to Retire, Malte Peters Appointed Successor - GlobeNewsWire
- 5 weeks ago - Tango Therapeutics Appoints Sung Lee to Board of Directors - GlobeNewsWire
- 2 months ago - Tango Therapeutics to Participate in 44th Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 2 months ago - Tango Therapeutics to Participate in the Piper Sandler 37th Annual Healthcare Conference - GlobeNewsWire
- 2 months ago - Tango Therapeutics: PRMT5 Inhibitor Vopimetostat Approaches Pivotal Testing - Buy - Seeking Alpha
- 3 months ago - Tango Therapeutics, Inc. (TNGX) Discusses Positive Clinical Data and Development Plans for Vopimetostat in MTAP-deleted Cancers Transcript - Seeking Alpha
- 3 months ago - Tango Therapeutics Touts Encouraging Data From Early-Stage Cancer Trial, Raises Capital To Fund Advancement - Benzinga